SOURCE: BDI Pharma, Inc.

BDI Pharma, Inc.

January 24, 2011 12:18 ET

BDI Pharma's ConsignAdvantage Enjoys Landmark Growth; Completing Its 12th Year, Consignment Program Continues to Appeal to Marketplace

COLUMBIA, SC--(Marketwire - January 24, 2011) - BDI Pharma, Inc. (BDI), the nation's fastest growing national distributor of biotech therapies, announced unprecedented growth in the company's ConsignAdvantage® program. ConsignAdvantage, BDI Pharma's industry recognized biopharmaceutical consignment distribution program, experienced its Units of Product Distributed increase by more than twenty-five percent (25%) over the number distributed in 2009, while the program's membership grew by forty-two percent (42%) from January 1, 2010 to January 1, 2011. This expansion represented the largest single year increase for ConsignAdvantage in its twelve (12) year history.

"We are thrilled that ConsignAdvantage is recognized with greater and greater frequency as a viable solution to the budgetary constraints which medical providers are forced to combat in this current economic climate," stated Mollie E. Sharp, Director of ConsignAdvantage for BDI Pharma. "By allowing for increased departmental cash flow and reduced operating expenses, in conjunction with the ability to have product readily available when an emergent need arises, ConsignAdvantage continues to offer true value to its members." Added Christine Zinzeris, ConsignAdvantage Support Services Coordinator for BDI Pharma, "We look forward to expanding on the tremendous growth we have experienced over the last year and on developing new partnerships in 2011."

"Accessibility, affordability, convenience and simplicity -- these are the traits that have delineated the value proposition that BDI Pharma offers its customers and the manufacturing community through ConsignAdvantage," stated William A. Shirey, III, Executive Vice President of BDI Pharma. "Since 1999, our program model has been based on the premise that consignment does not have to be intrusive, nor does it require a technical degree in computer programming. By its design, ConsignAdvantage encourages transparency and partnership between the distributor and the end-user to enhance the latter's therapeutic capabilities; thus, ConsignAdvantage was created with the healthcare provider and with the patient equally in mind."

About BDI Pharma, Inc.

Since 1995, BDI Pharma has defined its customer-centric approach to serving the nation's healthcare community through innovative inventory supply solutions, unparalleled customer service, extensive product knowledge, 24/7 emergency availability and urgent need delivery. An open-access resource for reference material, educational literature, market data and online ordering, www.bdipharma.com (www.ivig.com) has become an industry-renowned point of reference. Proprietary programs for veterinarians -- www.4legpharma.com; product consignment -- www.consignadvantage.com; flu vaccine pre-booking -- www.securiflu.com; vaccine ordering -- www.securivax.com; and purchasing/reward programs -- www.qoreprogram.com and www.securigam.com round out a family of solutions tailored to the needs of the healthcare community at large.

BDI Pharma's portfolio includes branded and generic specialty pharmaceuticals, chemotherapy products, vaccines, albumin, IVIG, coagulation factors, high-titer or "hyper" immune globulins, and other specialty injectables. BDI Pharma is recognized as an "ADR," or Authorized Distributor of Record, for all of the manufacturers it represents.

Contact Information

  • Contact:
    Brad Davis
    Assistant Vice President, Marketing
    (800) 948-9834